A Study Evaluating the Single Subcutaneous Injection of Ebronucimab in Healthy Male Chinese Subjects

Clinical trial NCT07043283 · COMPLETED

Trial details

NCT number: NCT07043283
Sponsor: Akeso
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects

Start date: 2025-10-20
Primary completion: 2026-02-07
Enrollment: 230

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.